MORGAN STANLEY PLC/CALL/ZOETIS/180/0.1/20.12.24 Share Price

Warrant

DE000MB35451

Real-time Bid/Ask 15:00:32 01/07/2024 BST
1.34 EUR / 1.37 EUR -0.37% Intraday chart for MORGAN STANLEY PLC/CALL/ZOETIS/180/0.1/20.12.24
Current month+23.64%
1 month+12.40%
Date Price Change
01/07/24 1.25 -8.09%
28/06/24 1.36 -2.86%
27/06/24 1.4 +22.81%
26/06/24 1.14 +6.54%
25/06/24 1.07 -14.40%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 09:03 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ZOETIS INC.
Issuer Morgan Stanley
WKN MB3545
ISINDE000MB35451
Date issued 02/02/2023
Strike 180 $
Maturity 20/12/2024 (172 Days)
Parity 10 : 1
Emission price 2.64
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.94
Lowest since issue 0.48
Spread 0.04
Spread %3.08%

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Sector
-
More about the company

Ratings for Zoetis Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Zoetis Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
173.4 USD
Average target price
210.2 USD
Spread / Average Target
+21.22%
Consensus